Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Hockey India on Monday announced the 20-member squad for the Men's Junior Asia Cup, a qual
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
Australian company to begin first human trial of coronavirus vaccine Last Updated : 16 Apr 2020 04:00:55 PM IST file photo An Australian company has called out for volunteers in the country's first human trial of a COVID-19 vaccine, expected to take place in coming weeks.
Clinical research company Nucleus Network revealed on Wednesday it would test the effectiveness and safety of a Recombinant Spike Protein Nanoparticle vaccine, NVX-CoV2373, developed by US based biotechnology company Novavax, reports Xinhua news agency.Paul Griffin, an infectious diseases physician and microbiologist from Nucleus Network told local media on Thursday that the human trial procedures would involve four phases, following strict protocols to make sure it was safe and effective before being released to the public."We still have to progress through all the stages of clinical trials and we have to make sure it is safe and effective before we proceed," Griffin said.According to the Nucleus Network, phase one of the trial was expected to begin in mid-May with preliminary results of effectiveness and safety available in July.Griffin said it would take roughly 12-18 months from now before the vaccine could be released to the public.A small group of healthy volunteers would be recruited for the trial to test the effectiveness of this vaccine and according to Griffin, there was absolutely no chance that they could be infected with the disease by taking part.The World Health Organization estimated at least 20 other COVID-19 candidate vaccines are in development around the world.IANS Canberra For Latest Updates Please-
Join us on
Follow us on
172.31.16.186